Identification and functional analysis of genes from mouse primordial germ cells that are implicated in the epigenetic reprogramming of the genome

Project Information

GENOMIC REPROGRAMMIN

Grant agreement ID: 514427

Project closed

Start date 1 January 2005

End date 31 December 2006

Funded under

• Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Total cost No data

EU contribution € 159 046,00

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom

Objective

Development from a totipotent zygote into an adult occurs essentially without changes in DNA sequences but involves epigenetic mechanisms. This includes modifications of histones and DNA such as methylation, which regulate expression of specific set of genes present in all cells. Similar mechanisms are also involved during differentiation of pluri potent stem cells. These modifications are however reversible, for example, when somatic nuclei re-acquire totipotency when transplanted into oocytes. There is also an extensive erasure of most of the pre-existing epigenetic information in primordial germ cells (PGCs) immediately after their entry into the developing gonads, which provides a unique opportunity to discover the mechanism of epigenetic reprogramming of the genome. PGCs until about E10.5 possess modifications of the DNA that are similar to those in somatic cells, such as DNA methylation of specific regulatory elements, as well as the inactive X chromosome. However, when PGCs enter into the developing gonads, this information is erased, rapidly and substantially by E12.5.

This process is prerequisite for subsequent totipotency of the zygote. I propose to identify and study the key genes involved in the erasure of epigenetic information from PGCs. PGCs will be isolated from genital ridges at E10 and from E11.5. Key candidate genes that are activated between E10.0 and E11.5 will be identified using Representational Difference Analysis (RDA) and micro-array analysis. Subsequently, verification of their expression patterns will be carried out by in situ hybridisation and real time RT-PCR on PGCs isolated from E9.5 to E12.5. Functional analysis of the candidates will involve cell-based assays in vitro, and siRNA in ES cells. These modified ES cells will be introduced into host blastocysts, and PGCs from the resulting fetuses will be analysed for their effects on epigenetic reprogramming. I will also examine if any of these factors are inherited in oocytes to determine.

Fields of science

• natural sciences › biological sciences › genetics › DNA
• medical and health sciences › medical biotechnology › cells technologies › stem cells
• natural sciences › mathematics › pure mathematics › mathematical analysis › functional analysis
• medical and health sciences › clinical medicine › embryology
• natural sciences › biological sciences › genetics › genomes

Programme(s)

• FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006

Topic(s)

• MOBILITY-2.1 - Marie Curie Intra-European Fellowships (EIF)

Call for proposal

FP6-2002-MOBILITY-3
See other projects for this call

Funding Scheme

EIF - Marie Curie actions-Intra-European Fellowships

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

• EU contribution: No data
• Address: The Old Schools, Trinity Lane ; CAMBRIDGE ; United Kingdom
• Total cost: No data